(Q42505740)

1 November 2017

Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation (English)

1 reference

1 November 2017

5

1 reference

1 November 2017

G Cuomo

7

0 references

author name string

G Valentini

1

1 reference

1 November 2017

A Baroni

2

1 reference

1 November 2017

K Esposito

3

1 reference

1 November 2017

C Naclerio

4

1 reference

1 November 2017

A Farzati

6

1 reference

1 November 2017

B Farzati

8

1 reference

1 November 2017

1 May 2001

1 reference

Journal of Clinical Immunology

1 November 2017

1 reference

1 November 2017

21

1 reference

1 November 2017

3

1 reference

1 November 2017

210-217

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1011024313525

1 November 2017

0 references

cites work

Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension

1 reference

12 December 2020

Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion

1 reference

12 December 2020

Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma

1 reference

12 December 2020

Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy

1 reference

12 December 2020

Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease

1 reference

12 December 2020

The concept of type-1 and type-2 helper T cells and their cytokines in humans

1 reference

12 December 2020

Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis

1 reference

12 December 2020

Expression of Class II-MHC Antigens in the Dermis of Patients with Progressive Systemic Sclerosis

1 reference

12 December 2020

Scleroderma renal crisis analysis of prevalence and outcome in a large italian series

1 reference

12 December 2020

Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis

1 reference

12 December 2020

Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes

1 reference

12 December 2020

Cytokine production and serum levels in systemic sclerosis

1 reference

12 December 2020

Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations

1 reference

12 December 2020

Decreased lymphocyte blastogenesis, IL2 production and NK activity following nifedipine administration to healthy humans

1 reference

12 December 2020

D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis

1 reference

12 December 2020

Dermal mast cell degranulation in systemic sclerosis

1 reference

12 December 2020

Sequential dermal microvascular and perivascular changes in the development of scleroderma

1 reference

12 December 2020

In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases

1 reference

12 December 2020

Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis

1 reference

12 December 2020

Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve

1 reference

12 December 2020

[Lung interstitial disease in systemic sclerosis: semiologic characteristics with high-resolution computerized tomography and comparison with other methods]

1 reference

12 December 2020

Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor α, and Interferon-γ Levels in Sera from Patients With Scleroderma

1 reference

12 December 2020

Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.

1 reference

12 December 2020

Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations

1 reference

12 December 2020

Increased interferon-gamma (IFN-gamma) levels produced in vitro by alloactivated T lymphocytes in systemic sclerosis and Raynaud's phenomenon

1 reference

12 December 2020

Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies

1 reference

12 December 2020

Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis

1 reference

12 December 2020

Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis

1 reference

12 December 2020

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

1 reference

12 December 2020

Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis

1 reference

12 December 2020

Increased levels of alternatively spliced interleukin 4 (IL-4delta2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis

1 reference

12 December 2020

Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration

1 reference

12 December 2020

Increased Expression of CD40 Ligand in Activated CD4+T Lymphocytes of Systemic Sclerosis Patients

1 reference

12 December 2020

Polyclonal B lymphocyte activation in progressive systemic sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011024313525

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference